Animal cells and systems

The Korean Society for Integrative Biology (한국통합생물학회)
권호 표지

Cytokines Regulate the Expression of the Thymus and Activation-Regulated Chemokine (TARC; CCL17) in Human Skin Fibroblast Cells

  • Lee, Ji-Sook (Department of Biology, Daejeon University) ;
  • Kim, In-Sik (Department of Clinical Laboratory Science, School of Medicine, Eulji University) ;
  • Kim, Dong-Hee (Department of Pathology, College of Oriental Medicine, Daejeon University) ;
  • Yun, Chi-Young (Department of Biology, Daejeon University)
  • Published : 2006.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Allergic inflammation is thought to be a Th2 cell-dominant immune response during which tissue-resident fibroblasts produce chemokines which contribute to the recruitment of migratory leukocytes to sites of tissue injury. Thymus and activation-regulated chemokine (TARC; CCL17) is a potent member of the CC chemokine family and a selective chemoattractant for Th2 cells. In order to study the regulatory profiles of TARC production by $TNF-{\alpha}$, $IFN-{\gamma}$, and Il-4 in human normal skin fibroblast, CCD-986sk cell line was used. The expression of TARC protein was measured using ELISA, and mRNA level was detected by RT-PCR. The combination of $TNF-{\alpha}$ and IL-4 induced a time-and dose-dependent synergistic increase in the expression of TARC at both protein and mRNA levels in the cultured human skin fibroblasts. Exposure of the cells to single cytokine had no effect on TARC expression. The high concentration (100 ng/ml) and long incubation time (72 h) of $IFN-{\gamma}$ further enhanced the TARC production induced by $TNF-{\alpha}$/lL-4 in the skin fibroblast. This synergistic effect of Th1 and Th2 type cytokines on TARC production by skin fibroblasts may contribute to the inflammatory cell infiltration and tissue damage with allergic inflammation.

Keywords

References

  1. Cheng JF, Ott NL, Peterson EA, George TJ, Hukee MJ, Gleich GJ, and Leiferman KM (1997) Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. J Allergy Clin Immunol 99: 683-692 https://doi.org/10.1016/S0091-6749(97)70031-9
  2. Fukuda K, Fujitsu Y, Seki K, Kumagai N, and Nishida (2003) T Differential expression of thymus- and activation-regulated chemokine (CCLl7) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung. J Allergy Clin Immuno 111: 520-526 https://doi.org/10.1067/mai.2003.59
  3. Grewe M, Bruijnzeel-Koomen CA, Schopf E, Thepen T, Langeveld- Wildschut AG, Ruzicka T, and Krutmann J (1998). A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19: 359-361 https://doi.org/10.1016/S0167-5699(98)01285-7
  4. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, and Yoshie O (1997). The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 272: 15036-15042 https://doi.org/10.1074/jbc.272.23.15036
  5. Imai T, Yoshie O, Irimura T, Mizutani H, and Matsushima K (1999). Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104: 1097-1105 https://doi.org/10.1172/JCI7613
  6. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, and Tamaki K (2001). Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107: 535-541 https://doi.org/10.1067/mai.2001.113237
  7. Kakinuma T, Nakamura K, Wakugawa M, Yano S, Saeki H, Torii H, Komine M, Asahina A, and Tamaki K (2002). IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10kDA)/CXCL10 release by TNF-alpha and IFN-gamma in HaCaT cell line. Cytokine 20: 1-6 https://doi.org/10.1006/cyto.2002.1965
  8. Kim JE, Kim BJ, Jeong MS, Seo SJ, Kim MN, Hong CK, and Ro BI (2005). Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases. Korean Med Sci 20: 649-654 https://doi.org/10.3346/jkms.2005.20.4.649
  9. Kumagai N, Fukuda K, Ishimura Y, and Nishida T (2000). Synergistic induction of eotaxin expression in human keratocytes by TNF-{\alpha} and IL-4 or IL-13. Invest Ophthalmol Vis Sci 41: 1448-1453
  10. Kumagai N, Fukuda K, and Nishida T (2000). Synergistic effect of TNF-{\alpha} and IL-4 on the expression of thymus- and activation-regulated chemokine in human corneal fibroblasts. Biochem Biophys Res Commun 279: 1-5 https://doi.org/10.1006/bbrc.2000.3890
  11. Leung DY (2000). Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 105: 860-876 https://doi.org/10.1067/mai.2000.106484
  12. Moroi Y, Yu B, Urabe K, Koga T, Nakahara T, Dainichi T, Uchi H, Furue M (2004) Effects of MAPK inhibitors on CCR4-mediated chemotaxis against thymus and activation-regulated chemokine (TARC/CCL17). J Dermatol Sci 36: 186-188 https://doi.org/10.1016/j.jdermsci.2004.08.013
  13. Muller KM, Jaunin F, Masouye I, Saurat JH, and Hauser C (1993) .Th2 cells mediate IL-4-dependent local tissue inflammation. J Immunol 150: 5576-5584
  14. Nakazawa M, Sugi N, Kawaguchi H, Ishii N, Nakajima H, and Minami M (1997). Predominance of type cytokines-producing CD4+ and CD8+ cells in patients with atopic dermatitis. J Allergy Clin Immunol 99: 673-682 https://doi.org/10.1016/S0091-6749(97)70030-7
  15. Neumann C, Gutgesell C, Fliegert F, Bonifer R. and Herrmann F (1996). Comparative analysis of the frequency of house dust mite specific and nonspecific Th1 and Th2 cells in skin lesions and peripheral blood of patients with atopic dermatitis. J Mol Med 74: 401-406 https://doi.org/10.1007/s001090050041
  16. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, and Leung DY (2002). Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Eng J Med 347: 1151-1160 https://doi.org/10.1056/NEJMoa021481
  17. Reinhold V, Kukel S, Goeden B, Neumann U, and Kreysel HW (1991). Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis. Clin Exp Immunol 86: 444-448 https://doi.org/10.1111/j.1365-2249.1991.tb02951.x
  18. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, and Kay AB (1992). Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326: 298-304 https://doi.org/10.1056/NEJM199201303260504
  19. Smith RS, Smith TJ, Blieden TM, and Phipps RP (1997). Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 151: 317-322
  20. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, and Geha RS (1999). Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 103: 1103-1111 https://doi.org/10.1172/JCI5669
  21. Sumiyoshi K, Nakao A, Setoguchi Y, Tsuboi R, Okumura K, Ogawa H (2003). TGF-beta/Smad signaling inhibits IFN-gamma and TNF-alpha-induced TARC (CCL17) production in HaCaT cells. J Dermatol Sci 31: 53-58 https://doi.org/10.1016/S0923-1811(02)00141-X
  22. Tensen CP, Flier J, Van Der Raaij-Helmer EM, Sampat-Sardjoepersad S, Van Der Schors RC, Leurs R, Scheper RJ, Boorsma DM, and Willemze R (1999). Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3).J Invest Dermatol 112: 716-722 https://doi.org/10.1046/j.1523-1747.1999.00581.x
  23. Terr AI (2001). The atopic diseases. In: Parslow TG, Stites DP, Terr AI, and Imboden JB (eds), Medical Immunology. 10th Ed. Lange Medical Books, New York, p 349
  24. Van der Heijden FL, Wierenga EA, Bos JD, and Kapsenberg ML (1991). High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 97: 389-394 https://doi.org/10.1111/1523-1747.ep12480966
  25. van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, Maggi E, Romagnani S, Westland JK, and Mudde GC (1992). Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 90: 184-193 https://doi.org/10.1016/0091-6749(92)90070-I
  26. Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, Imai T, Yoshie O, lrimura T, Mizutani H, and Matsushima K (1999). Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104: 1097-1105 https://doi.org/10.1172/JCI7613
  27. Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, and Larsen CG (2000). A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 115: 640-646 https://doi.org/10.1046/j.1523-1747.2000.00115.x
  28. Werfel T, Morita A, Grewe M, Renz H, Kmtmann J, and Kapp A (1996). Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitisJ. Invest Dermatol 107: 871-876 https://doi.org/10.1111/1523-1747.ep12331164
  29. Xiao T, Fujita H, Saeki H, Mitsui H, Sugaya M, Tada Y, Kakinuma T, Torii H, Nakamura K, Asahina A, and Tamaki K (2003). Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma. Cytokine 23: 126-132 https://doi.org/10.1016/S1043-4666(03)00221-7
  30. Yamamoto S, Hamasaki Y, Ishii E, Ichimaru T, and Miyazaki S (1997). Unbalanced production of interleukin-5 and interleukin-2 in children with atopic dermatitis. Ann Allergy Asthma Immunol 78: 517-523 https://doi.org/10.1016/S1081-1206(10)63241-3
  31. Yoshie O, Imai T, and Nomiyama H (2001). Chemokines in immunity. Adv Immunol 78: 57-110 https://doi.org/10.1016/S0065-2776(01)78002-9